COLTENE Holding
Market Cap
CHF537.8m
Last Updated
2020/02/16 21:02 UTC
Data Sources
Company Financials +
Executive Summary
COLTENE Holding AG develops, manufactures, and sells consumables and small equipment for dental practices in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.
Rewards
Risk Analysis
Snowflake Analysis
Good value with reasonable growth potential.
Share Price & News
How has COLTENE Holding's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLTN has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
3.4%
CLTN
1.7%
CH Medical Equipment
1.0%
CH Market
1 Year Return
-7.4%
CLTN
29.6%
CH Medical Equipment
17.9%
CH Market
Return vs Industry: CLTN underperformed the Swiss Medical Equipment industry which returned 29.6% over the past year.
Return vs Market: CLTN underperformed the Swiss Market which returned 17.9% over the past year.
Shareholder returns
| CLTN | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.4% | 1.7% | 1.0% |
| 30 Day | -4.2% | 3.8% | 2.2% |
| 90 Day | 10.3% | 6.8% | 7.3% |
| 1 Year | -4.6%-7.4% | 30.8%29.6% | 23.6%17.9% |
| 3 Year | 18.4%6.6% | 97.6%91.0% | 41.3%24.0% |
| 5 Year | 67.2%40.6% | 167.8%150.5% | 47.5%24.0% |
Price Volatility Vs. Market
How volatile is COLTENE Holding's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Should You Buy COLTENE Holding AG (VTX:CLTN) For Its Dividend?3 weeks ago | Simply Wall St
Should You Investigate COLTENE Holding AG (VTX:CLTN) At CHF92.60?1 month ago | Simply Wall St
Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?Valuation
Is COLTENE Holding undervalued compared to its fair value and its price relative to the market?
23.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CLTN (CHF90) is trading below our estimate of fair value (CHF116.84)
Significantly Below Fair Value: CLTN is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CLTN is good value based on its PE Ratio (30.1x) compared to the Medical Equipment industry average (52.9x).
PE vs Market: CLTN is poor value based on its PE Ratio (30.1x) compared to the Swiss market (21.1x).
Price to Earnings Growth Ratio
PEG Ratio: CLTN is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: CLTN is good value based on its PB Ratio (6.8x) compared to the CH Medical Equipment industry average (6.8x).
Next Steps
Future Growth
How is COLTENE Holding forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
15.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLTN's forecast earnings growth (15.9% per year) is above the savings rate (-0.6%).
Earnings vs Market: CLTN's earnings (15.9% per year) are forecast to grow faster than the Swiss market (10.5% per year).
High Growth Earnings: CLTN's earnings are forecast to grow, but not significantly.
Revenue vs Market: CLTN's revenue (3.9% per year) is forecast to grow faster than the Swiss market (3.3% per year).
High Growth Revenue: CLTN's revenue (3.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLTN's Return on Equity is forecast to be high in 3 years time (24.7%)
Next Steps
Past Performance
How has COLTENE Holding performed over the past 5 years?
4.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLTN has high quality earnings.
Growing Profit Margin: CLTN's current net profit margins (6.6%) are lower than last year (10.9%).
Past Earnings Growth Analysis
Earnings Trend: CLTN's earnings have grown by 4.4% per year over the past 5 years.
Accelerating Growth: CLTN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CLTN had negative earnings growth (-13.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.5%).
Return on Equity
High ROE: CLTN's Return on Equity (21.2%) is considered high.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is COLTENE Holding's financial position?
Financial Position Analysis
Short Term Liabilities: CLTN's short term assets (CHF133.5M) exceed its short term liabilities (CHF99.1M).
Long Term Liabilities: CLTN's short term assets (CHF133.5M) exceed its long term liabilities (CHF7.2M).
Debt to Equity History and Analysis
Debt Level: CLTN's debt to equity ratio (83%) is considered high.
Reducing Debt: CLTN's debt to equity ratio has increased from 23.3% to 83% over the past 5 years.
Debt Coverage: CLTN's debt is well covered by operating cash flow (38.5%).
Interest Coverage: CLTN's interest payments on its debt are well covered by EBIT (42.6x coverage).
Balance Sheet
Inventory Level: CLTN has a high level of physical assets or inventory.
Debt Coverage by Assets: CLTN's debt is covered by short term assets (assets are 2x debt).
Next Steps
Dividend
What is COLTENE Holding's current dividend yield, its reliability and sustainability?
3.33%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: CLTN's dividend (3.33%) is higher than the bottom 25% of dividend payers in the Swiss market (1.71%).
High Dividend: CLTN's dividend (3.33%) is low compared to the top 25% of dividend payers in the Swiss market (3.34%).
Stability and Growth of Payments
Stable Dividend: CLTN's dividend payments have been volatile in the past 10 years.
Growing Dividend: CLTN's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (100.5%), CLTN's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CLTN's dividends in 3 years are forecast to be covered by earnings (62.5% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.1yrs
Average management tenure
CEO
Martin Schaufelberger (55yo)
7.7yrs
Tenure
CHF945,217
Compensation
Mr. Martin Schaufelberger has been the Chief Executive Officer of COLTENE Holding AG since June 1, 2012. Mr. Schaufelberger commands a long and very successful experience in leading mid-sized, companies op ...
CEO Compensation Analysis
Compensation vs Market: Martin's total compensation ($USD962.91K) is about average for companies of similar size in the Swiss market ($USD997.48K).
Compensation vs Earnings: Martin's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 7.7yrs | CHF945.22k | 0.18% CHF960.7k | |
| CFO & Deputy CEO | 6.1yrs | no data | 0.042% CHF225.8k | |
| Chief Operating Officer | 1.3yrs | no data | 0.91% CHF4.9m | |
| Vice President of Marketing | 5.1yrs | no data | 0.022% CHF117.6k | |
| Vice President of Sales | 5.1yrs | no data | 0.0066% CHF35.7k |
5.1yrs
Average Tenure
55yo
Average Age
Experienced Management: CLTN's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non-Executive Director | 10.8yrs | CHF87.67k | 0.10% CHF554.6k | |
| Chairman of the Board | 0yrs | CHF114.36k | 0.24% CHF1.3m | |
| Non-Executive Director | 14.1yrs | CHF91.44k | 0.088% CHF471.2k | |
| Non-Executive Director | 6.8yrs | CHF80.02k | 0.020% CHF107.8k | |
| Non-Executive Director | 4.1yrs | CHF70.00k | 0.0046% CHF25.0k | |
| Non-Executive Director | 2.9yrs | CHF79.65k | 0.0016% CHF8.7k | |
| Non-Executive Director | 1.4yrs | CHF19.63k | no data |
5.5yrs
Average Tenure
54yo
Average Age
Experienced Board: CLTN's board of directors are considered experienced (5.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.4%.
Top Shareholders
Company Information
COLTENE Holding AG's company bio, employee growth, exchange listings and data sources
Key Information
- Name: COLTENE Holding AG
- Ticker: CLTN
- Exchange: SWX
- Founded: 2005
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: CHF537.801m
- Shares outstanding: 5.98m
- Website: https://www.coltene.com
Number of Employees
Location
- COLTENE Holding AG
- Feldwiesenstrasse 20
- Altstätten
- St. Gallen
- 9450
- Switzerland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CLTN | SWX (SIX Swiss Exchange) | Yes | Registered Shares | CH | CHF | Jun 2006 |
| M3Z | DB (Deutsche Boerse AG) | Yes | Registered Shares | DE | EUR | Jun 2006 |
| CLHL.F | OTCPK (Pink Sheets LLC) | Yes | Registered Shares | US | USD | Jun 2006 |
| 0QP7 | LSE (London Stock Exchange) | Yes | Registered Shares | GB | CHF | Jun 2006 |
Biography
COLTENE Holding AG develops, manufactures, and sells consumables and small equipment for dental practices in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. It offers restoration products, including composites, bulk-fill composites, CAD/CAM solutions, composite veneering systems, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, characterizations, and parapulpal pins; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, endo accessories, and medicaments. The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electro surgery, surgical sundries, and occlusion verification products. In addition, it offers infection control products, which include ultrasonic cleaning units, face masks, patient bibs, and sterile and non-sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty, model making, waxes, occlusion control, accessories, HP burs, and silicone polishers. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was founded in 2005 and is headquartered in Altstätten, Switzerland.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/16 21:02 |
| End of Day Share Price | 2020/02/14 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.